VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $223,000 | +22200.0% | 1,121 | +11110.0% | 0.01% | – |
| Q4 2015 | $1,000 | -99.4% | 10 | -99.0% | 0.00% | -100.0% |
| Q3 2015 | $174,000 | -29.8% | 978 | -12.3% | 0.01% | -16.7% |
| Q2 2015 | $248,000 | +11.2% | 1,115 | -0.5% | 0.01% | +20.0% |
| Q1 2015 | $223,000 | +165.5% | 1,121 | +92.0% | 0.01% | +150.0% |
| Q4 2014 | $84,000 | -75.6% | 584 | -77.6% | 0.00% | -71.4% |
| Q1 2014 | $344,000 | +341.0% | 2,610 | +291.3% | 0.01% | +250.0% |
| Q4 2013 | $78,000 | -17.9% | 667 | -26.8% | 0.00% | -33.3% |
| Q3 2013 | $95,000 | +17.3% | 911 | -3.0% | 0.00% | 0.0% |
| Q2 2013 | $81,000 | +9.5% | 939 | -4.3% | 0.00% | +50.0% |
| Q1 2013 | $74,000 | +21.3% | 981 | -3.8% | 0.00% | 0.0% |
| Q4 2012 | $61,000 | +8.9% | 1,020 | 0.0% | 0.00% | 0.0% |
| Q3 2012 | $56,000 | +124.0% | 1,020 | +80.2% | 0.00% | +100.0% |
| Q2 2012 | $25,000 | -37.5% | 566 | -23.8% | 0.00% | 0.0% |
| Q1 2012 | $40,000 | +90.5% | 743 | +61.9% | 0.00% | 0.0% |
| Q4 2011 | $21,000 | +23.5% | 459 | 0.0% | 0.00% | 0.0% |
| Q3 2011 | $17,000 | -10.5% | 459 | +23.7% | 0.00% | 0.0% |
| Q2 2011 | $19,000 | – | 371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |